Expert Interview
Reviewing the potential of Medtronic's radio-frequency based Symplicity Spyral™ Renal Denervation (RDN) System for resistant hypertension
Ticker(s): MDT, ReCor MedicalInstitution: UCLA Medical Center
- Interventional cardiologist at UCLA , Medical Director of the Structural Heart Disease Program & Associate Clinical Professor of Medicine at the David Geffen School of Medicine.
- Manages 25 patients with ATTR-CM.
- Areas of expertise include coronary artery disease and structural and valvular heart disease while specializing in complex percutaneous coronary interventions including the use of rotational atherectomy.
Please describe your background and patient setting
How many patients with resistant hypertension do you manage?
Added By: ben_adminDo you utilize RDN systems in practice?
Added By: ben_adminWhat is your opinion of the Symplicity Spyra Renal Denervation System from Medtronic?
Added By: ben_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
